ECM
RVMD icon

ExodusPoint Capital Management’s Revolution Medicines RVMD Stock Holding History

ExodusPoint Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.7M Buy
+17,500
New +$1.77M 0.01% 845

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ExodusPoint Capital Management's RVMD Position: Q1 2026 in Review

ExodusPoint Capital Management opened a new position in Revolution Medicines (RVMD) in Q1 2026: 10,536 shares worth $1.02M. The stake represents 0.01% of the portfolio and ranks #989 among its holdings. This is a return to the name: ExodusPoint Capital Management previously reported a position in RVMD as recently as Q3 2025.

ExodusPoint Capital Management first reported a position in RVMD in Q4 2020 and has held it in 13 quarters since. The position peaked at $5.39M in Q4 2024. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • ExodusPoint Capital Management held 10,536 shares of Revolution Medicines worth $1.02M as of Q1 2026.
  • Revolution Medicines was a new ExodusPoint Capital Management position in Q1 2026.
  • Revolution Medicines made up 0.01% of ExodusPoint Capital Management's portfolio in Q1 2026, its #989 holding.
  • ExodusPoint Capital Management first reported a position in Revolution Medicines in Q4 2020 and has held it in 13 quarters since.
  • ExodusPoint Capital Management's Revolution Medicines position peaked at $5.39M in Q4 2024.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.